Instead of IPO, Aptalis takes $2.9bn acquisition offer from Forest Laboratories
- Drug Delivery
- Specialty Pharmaceuticals
- Includes Contract
- Payment Includes Cash
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.